SI c.1215T>A ;(p.F405L)

Variant ID: 3-164777019-A-T

NM_001041.3(SI):c.1215T>A;(p.F405L)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.

Frontiers In Immunology
Li, Na N; Wang, Jiahong J; Zhan, Xianquan X
Publication Date: 2021

Variant appearance in text: SI: 1215T>A; Phe405Leu
PubMed Link: 34887858
Variant Present in the following documents:
  • Table_4.xlsx, sheet 1
View BVdb publication page



Bispecific Antibodies: From Research to Clinical Application.

Frontiers In Immunology
Ma, Jiabing J; Mo, Yicheng Y; Tang, Menglin M; Shen, Junjie J; Qi, Yanan Y; Zhao, Wenxu W; Huang, Yi Y; Xu, Yanmin Y; Qian, Cheng C
Publication Date: 2021

Variant appearance in text: SI: F405L
PubMed Link: 34025638
Variant Present in the following documents:
  • fimmu-12-626616.pdf
View BVdb publication page



Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Vergoossen, Dana L E DLE; Plomp, Jaap J JJ; Gstöttner, Christoph C; Fillié-Grijpma, Yvonne E YE; Augustinus, Roy R; Verpalen, Robyn R; Wuhrer, Manfred M; Parren, Paul W H I PWHI; Dominguez-Vega, Elena E; van der Maarel, Silvère M SM; Verschuuren, Jan J JJ; Huijbers, Maartje G MG
Publication Date: 2021-03-30

Variant appearance in text: SI: F405L
PubMed Link: 33753489
Variant Present in the following documents:
  • Main text
  • pnas.202020635.pdf
View BVdb publication page



Characterization of a Novel Bispecific Antibody That Activates T Cells In Vitro and Slows Tumor Growth In Vivo.

Monoclonal Antibodies In Immunodiagnosis And Immunotherapy
Chornoguz, Olesya O; Leettola, Catherine N CN; Leander, Karen K; Brosnan, Kerry K; Emmell, Eva E; Chiu, Mark L ML; Santulli-Marotto, Sandra S
Publication Date: 2019-12

Variant appearance in text: SI: F405L
PubMed Link: 31825302
Variant Present in the following documents:
  • mab.2019.0035.pdf
View BVdb publication page



Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer.

Cancer Cell
Hellmann, Matthew D MD; Nathanson, Tavi T; Rizvi, Hira H; Creelan, Benjamin C BC; Sanchez-Vega, Francisco F; Ahuja, Arun A; Ni, Ai A; Novik, Jacki B JB; Mangarin, Levi M B LMB; Abu-Akeel, Mohsen M; Liu, Cailian C; Sauter, Jennifer L JL; Rekhtman, Natasha N; Chang, Eliza E; Callahan, Margaret K MK; Chaft, Jamie E JE; Voss, Martin H MH; Tenet, Megan M; Li, Xue-Mei XM; Covello, Kelly K; Renninger, Andrea A; Vitazka, Patrik P; Geese, William J WJ; Borghaei, Hossein H; Rudin, Charles M CM; Antonia, Scott J SJ; Swanton, Charles C; Hammerbacher, Jeff J; Merghoub, Taha T; McGranahan, Nicholas N; Snyder, Alexandra A; Wolchok, Jedd D JD
Publication Date: 2018-05-14

Variant appearance in text: SI: F405L
PubMed Link: 29657128
Variant Present in the following documents:
  • mmc3.xlsx, sheet 3
View BVdb publication page



Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange.

Proceedings Of The National Academy Of Sciences Of The United States Of America
Labrijn, Aran F AF; Meesters, Joyce I JI; de Goeij, Bart E C G BE; van den Bremer, Ewald T J ET; Neijssen, Joost J; van Kampen, Muriel D MD; Strumane, Kristin K; Verploegen, Sandra S; Kundu, Amitava A; Gramer, Michael J MJ; van Berkel, Patrick H C PH; van de Winkel, Jan G J JG; Schuurman, Janine J; Parren, Paul W H I PW
Publication Date: 2013-03-26

Variant appearance in text: SI: F405L
PubMed Link: 23479652
Variant Present in the following documents:
  • Main text
View BVdb publication page